Global compound status map / 42 countries

Orforglipron / Foundayo
by country.

This global guide resolves Orforglipron / Foundayo to its fda-approved us medicine with country-specific status elsewhere first, then connects that identity to 42 country guides across five regions. Each country card opens the official product and seller or supply records that must be checked before any claim about approval, availability, legality, or a vendor can be supported.

Choose your evidence route

Four useful next steps for Orforglipron / Foundayo.

Start with the question you actually need answered. Each route keeps the Orforglipron / Foundayo identity, official trial record, destination status, and comparison dataset separate.

Fast destination lookup

Choose one country. Open the right records.

Skip the full atlas when you already know the destination. The result keeps the compound identity, national product record, and seller or supply record separate.

42-country source routerOrforglipron / Foundayo / exact destination
Region
North America
Language
English
Reviewed
July 18, 2026
Exact country answer

Orforglipron / Foundayo in the United States

FOUNDAYO received FDA approval on April 1, 2026 under NDA 220934 for a defined adult weight-management population. The approval belongs to the exact tablets, label, manufacturer, prescription product, and US supply record. It does not transfer to a powder, research listing, imported presentation, or online product using the orforglipron name.

Evidence lane
FDA-approved medicine
Global identity
FDA-approved US medicine with country-specific status elsewhere
Live decision workspace

Compare Orforglipron / Foundayo with Semaglutide, without losing the country context.

Put evidence status, ClinicalTrials.gov coverage, official United States records, and qualified US research prices in one view. Blank fields stay blank when the underlying dataset does not support a number.

Open this comparison Choose any two records
AIdentity record
Orforglipron / Foundayo

FDA-approved US medicine with country-specific status elsewhere

No linked research price board
Destination fixedUnited StatesNorth America

Official product and seller records attached

BComparison record
Semaglutide

Product-specific approved medicine records in multiple jurisdictions

No linked research price board
01 · Status02 · Trials03 · Country04 · Price
Worldwide status answer

No one-word global verdict.

FOUNDAYO is an FDA-approved US oral medicine containing the non-peptide small molecule orforglipron. That US approval does not establish authorization, launch, prescription access, market presence, supply, or seller authority in another country, and it does not authenticate a same-name research or imported product.

Primary identity source: Current FOUNDAYO prescribing information / National Library of Medicine, DailyMed
Direct answers

The questions behind a worldwide search.

These answers define the evidence boundary. They do not provide medical or legal advice, a seller recommendation, or a country-wide availability claim.

01

Is Orforglipron / Foundayo legal or available in every country?

No single worldwide answer is supportable. Orforglipron / Foundayo begins here with a US FDA medicine identity, but the authorized brand, presentation, indication, prescription route, market status, and seller authority can differ by country. Verify the exact destination records below.

02

Can an online listing prove Orforglipron / Foundayo's local status?

No. A page using the name Orforglipron / Foundayo, a local currency, domestic delivery language, or a familiar vial image is only a lead. It does not prove the exact product identity, local authorization, current supply status, pharmacy or establishment license, import route, or seller authority.

03

What should I check before comparing Orforglipron / Foundayo suppliers?

Resolve Orforglipron / Foundayo through its primary identity record first. Then open the destination country's product database and its separate seller, pharmacy, establishment, or supply record. Compare offers only when the category, legal seller identity, exact presentation, delivery market, price, and source date all match.

Comparison method

Identity first. Country second. Seller third.

The same sequence works worldwide while the responsible authority, terminology, records, and available supply routes change by destination.

01

Resolve the exact name

Use the primary identity record for Orforglipron / Foundayo, including aliases and the correct research, clinical-pipeline, or medicine evidence lane.

02

Choose the destination

Open the country guide and match the exact product, presentation, current status, authorization holder, and supply route in the national record.

03

Verify the seller separately

Resolve the legal seller, pharmacy, clinic, establishment, or importer in the applicable official register before comparing a claim, price, or delivery route.

Five world regions

Start broad, then land on the country record.

Each regional summary preserves the compound’s evidence lane and links to every maintained national verification route in that part of the world.

0116 country guides

Orforglipron / Foundayo in Europe

Orforglipron / Foundayo in Europe begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.

025 country guides

Orforglipron / Foundayo in Latin America

Orforglipron / Foundayo in Latin America begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.

0314 country guides

Orforglipron / Foundayo in Asia-Pacific

Orforglipron / Foundayo in Asia-Pacific begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.

042 country guides

Orforglipron / Foundayo in North America

Orforglipron / Foundayo in North America begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.

055 country guides

Orforglipron / Foundayo in Middle East and Africa

Orforglipron / Foundayo in Middle East and Africa begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.

Europe / 16 destinations

Orforglipron / Foundayo in Europe.

Orforglipron / Foundayo in Europe begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.

01
FranceFrançais / updated 18 juillet 2026

Orforglipron / Foundayo en France

Orforglipron / Foundayo commence ici par une référence de médicament de la FDA américaine. Cela ne prouve pas le même produit, la même présentation, l’autorisation, le statut de prescription ou la disponibilité actuelle en France. Consultez les registres locaux exacts ci-dessous.

02
United KingdomEnglish / updated July 18, 2026

Orforglipron / Foundayo in the United Kingdom

Orforglipron / Foundayo begins here with a US FDA medicine identity. That does not prove the same product, presentation, approval, prescription status, or current availability in the United Kingdom. Verify the exact local records below.

03
DeutschlandDeutsch / updated 18. Juli 2026

Orforglipron / Foundayo in Deutschland

Orforglipron / Foundayo beginnt hier mit einer Arzneimittelreferenz der US-FDA. Das belegt weder dasselbe Produkt noch Darreichungsform, Zulassung, Verschreibungsstatus oder aktuelle Verfügbarkeit in Deutschland. Prüfe die genauen lokalen Register unten.

04
EspañaEspañol / updated 18 de julio de 2026

Orforglipron / Foundayo en España

Orforglipron / Foundayo empieza aquí con una referencia de medicamento de la FDA estadounidense. Eso no demuestra el mismo producto, presentación, aprobación, estado de prescripción ni disponibilidad actual en España. Verifica los registros locales exactos que aparecen abajo.

05
ItaliaItaliano / updated 18 luglio 2026

Orforglipron / Foundayo in Italia

Orforglipron / Foundayo parte qui da un riferimento di farmaco della FDA statunitense. Questo non dimostra stesso prodotto, presentazione, approvazione, stato di prescrizione o disponibilità attuale in Italia. Controlla i registri locali esatti qui sotto.

06
NederlandNederlands / updated 18 juli 2026

Orforglipron / Foundayo in Nederland

Orforglipron / Foundayo begint hier met een geneesmiddelreferentie van de Amerikaanse FDA. Dat bewijst niet hetzelfde product, dezelfde presentatie, toelating, receptstatus of actuele beschikbaarheid in Nederland. Controleer de exacte lokale registers hieronder.

07
SwitzerlandEnglish / updated July 18, 2026

Orforglipron / Foundayo in Switzerland

Orforglipron / Foundayo begins here with a US FDA medicine identity. That does not prove the same product, presentation, approval, prescription status, or current availability in Switzerland. Verify the exact local records below.

08
PolskaPolski / updated 18 lipca 2026

Orforglipron / Foundayo w Polsce

Orforglipron / Foundayo zaczyna się tutaj od dokumentu leku amerykańskiej FDA. Nie dowodzi to tego samego produktu, postaci, dopuszczenia, statusu recepty ani bieżącej dostępności w Polsce. Sprawdź dokładne rejestry krajowe poniżej.

09
IrelandEnglish / updated July 18, 2026

Orforglipron / Foundayo in Ireland

Orforglipron / Foundayo begins here with a US FDA medicine identity. That does not prove the same product, presentation, approval, prescription status, or current availability in Ireland. Verify the exact local records below.

10
PortugalPortuguês (Portugal) / updated 18 de julho de 2026

Orforglipron / Foundayo em Portugal

Orforglipron / Foundayo começa aqui com uma referência de medicamento da FDA dos EUA. Isso não comprova o mesmo produto, apresentação, autorização, estatuto de prescrição ou disponibilidade atual em Portugal. Consulte os registos locais exatos abaixo.

11
SverigeSvenska / updated 18 juli 2026

Orforglipron / Foundayo i Sverige

Orforglipron / Foundayo börjar här med en läkemedelsreferens från amerikanska FDA. Det bevisar inte samma produkt, presentation, godkännande, receptstatus eller aktuell tillgänglighet i Sverige. Kontrollera de exakta nationella registren nedan.

12
TürkiyeTürkçe / updated 18 Temmuz 2026

Türkiye için Orforglipron / Foundayo

Orforglipron / Foundayo kimliği burada bir ABD FDA ilaç kaydıyla başlar, ancak bu Türkiye için aynı ürünün, farmasötik şeklin, dozun, ruhsatın, reçete durumunun veya güncel tedarikin bulunduğunu kanıtlamaz. Aşağıdaki resmi kayıtlarla tam ürün ve satıcı kimliğini, güncel durumu ve iddia edilen yolu doğrulayın.

13
ÖsterreichDeutsch / updated 18. Juli 2026

Orforglipron / Foundayo in Österreich

Orforglipron / Foundayo beginnt hier mit einer Arzneimittelreferenz der US-FDA. Das belegt weder dasselbe Produkt noch Darreichungsform, Zulassung, Verschreibungsstatus oder aktuelle Verfügbarkeit in Österreich. Prüfe die genauen lokalen Register unten.

14
BelgiëNederlands / updated 18 juli 2026

Orforglipron / Foundayo in België

Orforglipron / Foundayo begint hier met een geneesmiddelreferentie van de Amerikaanse FDA. Dat bewijst niet hetzelfde product, dezelfde presentatie, toelating, receptstatus of actuele beschikbaarheid in België. Controleer de exacte lokale registers hieronder.

15
DanmarkDansk / updated 18. juli 2026

Orforglipron / Foundayo i Danmark

Orforglipron / Foundayo begynder her med en amerikansk FDA-lægemiddelidentitet, men det dokumenterer ikke samme produkt, form, styrke, godkendelse, receptstatus eller aktuelle forsyning i Danmark. Brug de officielle registre nedenfor til at kontrollere det nøjagtige lokale produkt, sælgeren, status og den påståede rute.

16
SuomiSuomi / updated 18. heinäkuuta 2026

Orforglipron / Foundayo kohteessa Suomi

Orforglipron / Foundayo alkaa tässä Yhdysvaltain FDA:n lääkeidentiteetistä, mutta se ei todista samaa tuotetta, lääkemuotoa, vahvuutta, hyväksyntää, reseptistatusta tai nykyistä toimitusta kohteessa Suomi. Tarkista täsmällinen paikallinen tuote, myyjä, tila ja väitetty reitti alla olevista virallisista rekistereistä.

Latin America / 5 destinations

Orforglipron / Foundayo in Latin America.

Orforglipron / Foundayo in Latin America begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.

01
MéxicoEspañol / updated 18 de julio de 2026

Orforglipron / Foundayo en México

Orforglipron / Foundayo empieza aquí con una referencia de medicamento de la FDA estadounidense. Eso no demuestra el mismo producto, presentación, aprobación, estado de prescripción ni disponibilidad actual en México. Verifica los registros locales exactos que aparecen abajo.

02
ArgentinaEspañol / updated 18 de julio de 2026

Orforglipron / Foundayo en Argentina

Orforglipron / Foundayo empieza aquí con una referencia de medicamento de la FDA estadounidense. Eso no demuestra el mismo producto, presentación, aprobación, estado de prescripción ni disponibilidad actual en Argentina. Verifica los registros locales exactos que aparecen abajo.

03
ColombiaEspañol / updated 18 de julio de 2026

Orforglipron / Foundayo en Colombia

Orforglipron / Foundayo empieza aquí con una referencia de medicamento de la FDA estadounidense. Eso no demuestra el mismo producto, presentación, aprobación, estado de prescripción ni disponibilidad actual en Colombia. Verifica los registros locales exactos que aparecen abajo.

04
ChileEspañol / updated 18 de julio de 2026

Orforglipron / Foundayo en Chile

Orforglipron / Foundayo empieza aquí con una referencia de medicamento de la FDA estadounidense. Eso no demuestra el mismo producto, presentación, aprobación, estado de prescripción ni disponibilidad actual en Chile. Verifica los registros locales exactos que aparecen abajo.

05
BrasilPortuguês (Brasil) / updated 18 de julho de 2026

Orforglipron / Foundayo no Brasil

Orforglipron / Foundayo começa aqui com uma referência de medicamento da FDA dos EUA. Isso não comprova o mesmo produto, apresentação, aprovação, status de prescrição ou disponibilidade atual no Brasil. Consulte os registros locais exatos abaixo.

Asia-Pacific / 14 destinations

Orforglipron / Foundayo in Asia-Pacific.

Orforglipron / Foundayo in Asia-Pacific begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.

01
中国简体中文 / updated 2026年7月18日

Orforglipron / Foundayo 在中国的状态与官方记录

Orforglipron / Foundayo在此从美国 FDA 药品身份记录开始,但这不能证明同一品牌、剂型、规格、适应症、处方状态或供应路径在中国同样获批或可得。应使用下方官方记录核对目的地的具体产品和卖方,并确认当前状态,而不是依据名称、包装图片或国外批准作出推断。

02
AustraliaEnglish / updated July 18, 2026

Orforglipron / Foundayo in Australia

Orforglipron / Foundayo begins here with a US FDA medicine identity. That does not prove the same product, presentation, approval, prescription status, or current availability in Australia. Verify the exact local records below.

03
New ZealandEnglish / updated July 18, 2026

Orforglipron / Foundayo in New Zealand

Orforglipron / Foundayo begins here with a US FDA medicine identity. That does not prove the same product, presentation, approval, prescription status, or current availability in New Zealand. Verify the exact local records below.

04
IndiaEnglish / updated July 18, 2026

Orforglipron / Foundayo in India

Orforglipron / Foundayo begins here with a US FDA medicine identity. That does not prove the same product, presentation, approval, prescription status, or current availability in India. Verify the exact local records below.

05
日本日本語 / updated 2026年7月18日

日本のOrforglipron / Foundayo

Orforglipron / Foundayoはここでは米国FDAの医薬品記録から同一性を確認しますが、日本で同じ製品、剤形、規格、承認、処方区分、供給状況が存在することを証明しません。下記の公的記録で目的地の具体的な製品と販売主体を確認してください。

06
대한민국한국어 / updated 2026년 7월 18일

대한민국의 Orforglipron / Foundayo

Orforglipron / Foundayo은 여기서 미국 FDA 의약품 기록으로 신원을 시작하지만, 대한민국에서 같은 제품, 제형, 함량, 허가, 처방 상태 또는 현재 공급이 존재한다는 뜻은 아닙니다. 아래 공식 기록을 이용해 목적지의 구체적인 제품과 판매 주체를 확인하세요.

07
ประเทศไทยไทย / updated 18 กรกฎาคม 2569

Orforglipron / Foundayo ในประเทศไทย

Orforglipron / Foundayo เริ่มจากบันทึกยาของ FDA สหรัฐฯ แต่ไม่ได้พิสูจน์ว่าผลิตภัณฑ์ รูปแบบ ความแรง การอนุมัติ สถานะใบสั่งยา หรือการจัดหาในประเทศไทยเหมือนกัน ให้ตรวจผลิตภัณฑ์และผู้ขายที่เฉพาะเจาะจงในประเทศปลายทางจากบันทึกทางการด้านล่าง

08
IndonesiaBahasa Indonesia / updated 18 Juli 2026

Orforglipron / Foundayo di Indonesia

Orforglipron / Foundayo dimulai dari identitas obat dalam catatan FDA Amerika Serikat, tetapi hal itu tidak membuktikan produk, bentuk, kekuatan, persetujuan, status resep, atau pasokan yang sama di Indonesia. Gunakan catatan resmi di bawah untuk memeriksa produk dan penjual spesifik di negara tujuan.

09
SingaporeEnglish / updated July 18, 2026

Orforglipron / Foundayo in Singapore

Orforglipron / Foundayo begins here with a US FDA medicine identity. That does not prove the same product, presentation, approval, prescription status, or current availability in Singapore. Verify the exact local records below.

10
PhilippinesEnglish / updated July 18, 2026

Orforglipron / Foundayo in the Philippines

Orforglipron / Foundayo begins here with a US FDA medicine identity. That does not prove the same product, presentation, approval, prescription status, or current availability in the Philippines. Verify the exact local records below.

11
MalaysiaEnglish / updated July 18, 2026

Orforglipron / Foundayo in Malaysia

Orforglipron / Foundayo begins here with a US FDA medicine identity. That does not prove the same product, presentation, approval, prescription status, or current availability in Malaysia. Verify the exact local records below.

12
台灣繁體中文(台灣) / updated 2026年7月18日

Orforglipron / Foundayo 在台灣的紀錄

Orforglipron / Foundayo在此從美國 FDA 藥品紀錄確認身分,但這不能證明台灣有相同產品、劑型、含量、適應症、處方狀態或目前供應。請用下方官方紀錄查證目的地的特定產品、許可證、機構和提供者,不能只依名稱或外國核准推論。

13
香港繁體中文(香港) / updated 2026年7月18日

Orforglipron / Foundayo 在香港的紀錄

Orforglipron / Foundayo在此從美國 FDA 藥物紀錄確認身分,但這不能證明香港有相同產品、劑型、含量、適應症、處方狀態或目前供應。請用下方官方紀錄核實指定產品、註冊編號、持牌銷售商和現行狀態,不能只依名稱或外國批准推論。

14
Việt NamTiếng Việt / updated 18 tháng 7 năm 2026

Orforglipron / Foundayo tại Việt Nam

Orforglipron / Foundayo bắt đầu ở đây bằng hồ sơ thuốc của FDA Hoa Kỳ, nhưng điều đó không chứng minh có cùng sản phẩm, dạng bào chế, hàm lượng, giấy phép, tình trạng kê đơn hay nguồn cung hiện tại tại Việt Nam. Hãy dùng các hồ sơ bên dưới để xác minh chính xác sản phẩm, người bán, tình trạng và đường cung ứng tại điểm đến.

North America / 2 destinations

Orforglipron / Foundayo in North America.

Orforglipron / Foundayo in North America begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.

01
United StatesEnglish / updated July 18, 2026

Orforglipron / Foundayo in the United States

FOUNDAYO received FDA approval on April 1, 2026 under NDA 220934 for a defined adult weight-management population. The approval belongs to the exact tablets, label, manufacturer, prescription product, and US supply record. It does not transfer to a powder, research listing, imported presentation, or online product using the orforglipron name.

Middle East and Africa / 5 destinations

Orforglipron / Foundayo in Middle East and Africa.

Orforglipron / Foundayo in Middle East and Africa begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.

01
الإمارات العربية المتحدةالعربية / updated 18 يوليو 2026

Orforglipron / Foundayo في الإمارات العربية المتحدة

تبدأ هوية Orforglipron / Foundayo هنا من سجل دواء لدى إدارة الغذاء والدواء الأمريكية، لكن ذلك لا يثبت أن المنتج أو الشكل أو التركيز أو الموافقة أو حالة الوصفة أو التوفر الحالي هي نفسها في الإمارات العربية المتحدة. تحقق من المنتج المحلي المحدد والمنشأة والبائع ومسار التوريد من خلال السجلات الرسمية أدناه.

02
المملكة العربية السعوديةالعربية / updated 18 يوليو 2026

Orforglipron / Foundayo في المملكة العربية السعودية

تبدأ هوية Orforglipron / Foundayo هنا من سجل دواء لدى إدارة الغذاء والدواء الأمريكية، لكن ذلك لا يثبت أن المنتج أو الشكل أو التركيز أو الموافقة أو حالة الوصفة أو التوفر الحالي هي نفسها في المملكة العربية السعودية. تحقق من المنتج المحلي المحدد والمنشأة والبائع ومسار التوريد من خلال السجلات الرسمية أدناه.

03
South AfricaEnglish / updated July 18, 2026

Orforglipron / Foundayo in South Africa

Orforglipron / Foundayo begins here with a US FDA medicine identity. That does not prove the same product, presentation, approval, prescription status, or current availability in South Africa. Verify the exact local records below.

04
NigeriaEnglish / updated July 18, 2026

Orforglipron / Foundayo in Nigeria

Orforglipron / Foundayo begins here with a US FDA medicine identity. That does not prove the same product, presentation, approval, prescription status, or current availability in Nigeria. Verify the exact local records below.

05
KenyaEnglish / updated July 18, 2026

Orforglipron / Foundayo in Kenya

Orforglipron / Foundayo begins here with a US FDA medicine identity. That does not prove the same product, presentation, approval, prescription status, or current availability in Kenya. Verify the exact local records below.

Audit the work

Every conclusion stays attached to a source route.

The compound identity source is linked above. Every country card links its national product and seller or supply records, then opens a localized guide with the full verification boundary.

Open the Orforglipron / Foundayo identity record →Compare Orforglipron / Foundayo across 50 US states →Compare Orforglipron / Foundayo across 10 Canadian provinces →Download all 1722 compound-country rows →Download all 2050 compound-state rows →Download all 410 compound-province rows →Audit the regional access dataset →Review the complete source registry →Read the publication standard →